Observational studyAmerican journal of respiratory and critical care medicine2024
The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort Study.
Open access · greenAbstract readObservational Study
In one paragraph
Observational study in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 10 citations in OpenAlex.
- Effect of chronic high-altitude exposure on postoperative pulmonary complications: a retrospective cohort study.Annals of medicine · 2026Article
- High-Altitude Residence, Blood Biomarkers, and Chronic Disease Risk in Middle-Aged and Older Chinese Adults.Healthcare (Basel, Switzerland) · 2026Article
- Friend or foe: Face masks in patients with COPD at high altitude.Physiological reports · 2026Review
- Risk of bleeding in transbronchial biopsies in patients with pulmonary hypertension.Scientific reports · 2026Article
- Chronic Hypobaric Hypoxia at High Altitudes Aggravates Chronic Obstructive Pulmonary Disease in Mice.Journal of inflammation research · 2026Article
- Chronic Obstructive Pulmonary Disease and Multimorbidity: Insights from a National Claims Administrative Database.International journal of chronic obstructive pulmonary disease · 2026Article
- Effect of High Altitude on Small Pulmonary Vein and Artery Volume in the COPDGene Cohort: Towards Better Understanding of Lung Physiology and Pulmonary Disease.Journal of personalized medicine · 2025Article
- Geographic Variation in Prevalence of Breathlessness: Latitude.American journal of respiratory and critical care medicine · 2025Article
- Reply to CurrowAmerican journal of respiratory and critical care medicine · 2025Article
- Intranasal Administration of Acetaminophen-Loaded Poly(lactic-Pharmaceutics · 2025Article
- Validation of new predictors of mortality and BODE index variants in patients with COPD at moderate altitude.ERJ open research · 2025Article
- Exercise Dysfunction and Pulmonary Rehabilitation Strategies in COPD Patients at High-Altitudes: A Review.International journal of chronic obstructive pulmonary disease · 2025Review
- The Impact of the Chronic High-Altitude Environment on Chronic Obstructive Pulmonary Disease Outcomes.American journal of respiratory and critical care medicine · 2024Article
Corrections and comments
- Commented on by
Authors and funding
27 authors at 20 institutions in 1 country.
Rajat SuriDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of California, San Diego, La Jolla, California.ORCID 0000-0002-9025-7138
Daniela MarkovicDivision of General Internal Medicine and Health Services Research.ORCID 0009-0003-7128-280X
Han WooDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland.
Mehrdad ArjomandiDepartment of Medicine, University of California, San Francisco, San Francisco, California.ORCID 0000-0002-0116-9217
R Graham BarrDepartment of Medicine and.
Russell P BowlerDepartment of Medicine, National Jewish Health, Denver, Colorado.ORCID 0000-0003-4651-363X
Gerard CrinerDepartment of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.ORCID 0000-0003-1267-3483
Jeffrey L CurtisDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-5191-4847
Mark T DransfieldDepartment of Medicine, University of Alabama, Birmingham, Alabama.ORCID 0000-0002-9207-1820
M Bradley DrummondDivision of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.ORCID 0000-0002-6968-4610
Spyridon FortisDivision of Pulmonary, Critical Care and Occupation Medicine.ORCID 0000-0001-7807-6740
MeiLan K HanDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-9095-4419
Eric A HoffmanDepartment of Internal Medicine.ORCID 0000-0001-8456-9437
Robert J KanerDivision of Pulmonary and Critical Care, Weill Cornell Medicine, New York, New York.ORCID 0000-0003-0527-576X
Joel D KaufmanDepartment of Environmental and Occupational Health Sciences, Medicine, and Epidemiology, University of Washington, Seattle, Washington.ORCID 0000-0003-4174-9037
Jerry A KrishnanBreathe Chicago Center, University of Illinois Chicago, Chicago, Illinois.ORCID 0000-0001-5525-4778
Fernando J MartinezDivision of Pulmonary and Critical Care, Weill Cornell Medicine, New York, New York.ORCID 0000-0002-2412-3182
Jill OharDivision of Pulmonary, Critical Care, Allergy and Immunology, School of Medicine, Wake Forest University, Wake Forest, North Carolina.ORCID 0000-0002-2757-6806
Victor E OrtegaDivision of Respiratory Medicine, Department of Internal Medicine, Mayo Clinic, Scottsdale, Arizona.
Robert PaineDivision of Respiratory, Critical Care and Occupational Pulmonary Medicine, University of Utah, Salt Lake City, Utah.
Xavier SolerRegeneron Pharmaceuticals, Inc., Tarrytown, New York; and.
Prescott G WoodruffDepartment of Medicine, University of California, San Francisco, San Francisco, California.ORCID 0000-0003-3176-0603
Nadia N HanselDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland.ORCID 0000-0002-8740-9751
Christopher B CooperDivision of Pulmonary and Critical Care Medicine, and.ORCID 0000-0002-6314-0903
Donald P TashkinDivision of Pulmonary and Critical Care Medicine, and.ORCID 0000-0002-5607-4872
Russell G BuhrDivision of Pulmonary and Critical Care Medicine, and.ORCID 0000-0001-6159-7435
Igor Z BarjaktarevicDivision of Pulmonary and Critical Care Medicine, and.ORCID 0000-0002-8096-0858
Cornell University · USJohns Hopkins University · USPulmonary and Critical Care Associates · USUniversity of California, San Francisco · USUniversity of Michigan · USColumbia University Irving Medical Center · USHealth Services Research & Development · USIowa City VA Health Care System · USMayo Clinic in Arizona · USNational Jewish Health · USRegeneron (United States) · USTemple University · USUniversity of Alabama at Birmingham · USUniversity of California, Los Angeles · USUniversity of California System · USUniversity of Illinois Chicago · USUniversity of Iowa · USUniversity of North Carolina at Chapel Hill · USUniversity of Utah · USUniversity of Washington · US
Funding
XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI Nicole Ann Errett · 1995 to 2026
$42.5MSPIROMICS II: Biological underpinnings of COPD heterogeneity and progressionU01HL137880 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WOODRUFF, PRESCOTT G · 2017 to 2021
$27.9MThe Effect of Nanoparticle Encapsulated Resveratrol on Treatment of PeriodontitisKL2TR001882 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Elizabeta Nemeth · 2016 to 2026
$13.1MUnderstanding the Origins of Early COPDR01HL144718 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CURTIS, JEFFREY LOUIS, HAN, MEILAN K · 2020 to 2024
$11.3MSPIROMICS GIC SupportU24HL141762 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID J, O'NEAL, WANDA K · 2018 to 2022
$7.2MSPIROMICS - Air Pollution StudyR01ES023500 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI HANSEL, NADIA N, KAUFMAN, JOEL DANIEL · 2014 to 2018
$3.2MNHLBI NIH HHS HHSN268200900013CNHLBI NIH HHS HHSN268200900014CNHLBI NIH HHS HHSN268200900015CNHLBI NIH HHS HHSN268200900016CNHLBI NIH HHS HHSN268200900017CNHLBI NIH HHS HHSN268200900018CNHLBI NIH HHS HHSN268200900019CNHLBI NIH HHS HHSN268200900020CNHLBI NIH HHS R01 HL144718NHLBI NIH HHS U01 HL137880NHLBI NIH HHS U24 HL141762NIEHS NIH HHS R01 ES023500NIEHS NIH HHS R01ES023500
Abstract
PubMed holds no abstract for this paper.
Indexed as
AltitudePulmonary Disease, Chronic ObstructiveAgedCohort StudiesDisease ProgressionExercise ToleranceFemaleHumansMaleMiddle Agedaltitudechronic obstructive pulmonary diseaselongitudinal outcomespatient-centered outcomes
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.